188re-pti-6d2
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2007 (NCT00399113)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiodepletion
radiodepletion
Chemistry & pharmacology
- Payload
- 188-rhenium
Oral
No
Parenteral
No
Topical
No
Also known as
- 188re-pti-6d2
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00399113 | Phase 1 | May 1, 2007 | Cassava Sciences, Hebrew University, Tel Aviv University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cassava Sciences | For profit | 1 | 1 | 1 | 2007 |
| Hebrew University | Academic/Hospital | 1 | 0 | 1 | 2007 |
| Tel Aviv University | Academic/Hospital | 1 | 0 | 1 | 2007 |
3 organizations
Page 1 / 1